John Grubb was something of a celebrity when he left HCMC on Monday — crowds gathered for pictures at his bedside and nurses hugged the St. Michael, Minn., man and said goodbye.
When severe COVID-19 leaves you on a heart-lung bypass machine for 81 days, and you make it out of the hospital alive, you tend to get noticed.
"That's the longest we've had a survivor on veno-venous ECMO so far," said Dr. Matthew Prekker, a medical director of HCMC's ECMO program, who treated Grubb. "He's had the longest duration of support and fortunately is going to be a survivor."
ECMO is short for extracorporeal membrane oxygenation, a treatment of last resort that takes over the role of pumping oxygen and blood when the lungs are too weak to keep up. Globally, survival has been just a little better than 50-50 when COVID-19 patients end up needing ECMO for 60 days or more, but Twin Cities doctors said a combination of smart patient selection and patient critical care has pushed local survival rates above that.
A consortium of four Minnesota providers published data this month showing a 60-day survival rate of 74% in an initial group of 35 patients who received veno-venous (or VV) ECMO. Patients getting VV ECMO have their blood diverted out and mechanically oxygenated before it is run back into the body and through the lungs.
ECMO has been used for more than 100 COVID-19 patients in Minnesota and has been involved in some high-profile survival stories — such as Ironman athlete Ben O'Donnell and pianist Nachito Herrera.
Prekker said ECMO itself doesn't treat COVID-19 or its complications, but it gives the lungs and heart a break. The average duration of ECMO treatment has increased substantially in the COVID-19 era, he added, and doctors have learned they sometimes need to resist their urge to intervene and "sit on our hands" while healing takes place.
"It's really illustrated to me, having seen survivors after 50 or 60 or 80 days of ECMO, how resilient the lungs are," Prekker said. "They do have the chance to heal. We just need to give them enough time, as long as we're seeing other markers of success."